| Desiree I Smith, RN | |
|
701 W 18th St, Portales, NM 88130-7237 | |
| (575) 356-3675 | |
| (575) 359-3675 |
| Full Name | Desiree I Smith |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - School |
| Location | 701 W 18th St, Portales, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356854285 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WS0200X | Registered Nurse - School | R66027 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Desiree I Smith, RN 121 N Houston Ave, Portales, NM 88130-5627 Ph: (575) 749-2065 | Desiree I Smith, RN 701 W 18th St, Portales, NM 88130-7237 Ph: (575) 356-3675 |
News Archive
OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, presented in an oral presentation at the American Society of Anesthesiologists (ASA) annual meeting in San Diego, results showing that hemoglobin (Hb) measurements obtained by its NBM 200MP, a non-invasive Hb measurement system, showed accurate performance during hemorrhage conditions compared with invasive point of care (POC) devices.
Colorectal cancer is the third most common form of cancer and the second most common cause of cancer deaths in the United States. The chance of developing colorectal cancer increases with age. Now, a study by University of Missouri School of Medicine researchers shows that minority and ethnic groups are being diagnosed with colorectal cancer at younger ages and more advanced stages than non-Hispanic whites.
Acorda Therapeutics, Inc. today announced that the United States Patent and Trademark Office has allowed U.S. Patent Application No. 11/010,828 entitled "Sustained Release Aminopyridine Composition."
A scientist in the U.S. has developed a pill which has the same calorie-burning effect as a good work out at the gym.
For some patients with muscle-invasive bladder cancer, treatment may begin before they undergo cystectomy, or surgical removal of the bladder. They may be advised by oncologists to receive chemotherapy before surgery. A large randomized clinical trial published in 2003 demonstrated a survival benefit for neoadjuvant, or pre-surgical, MVAC (methotrexate, vinblastine, doxorubicin and cisplatin) using a standard dose and schedule.
› Verified 1 days ago
Ruth A Young, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 520 W 5th St, Portales, NM 88130 Phone: 575-356-7097 Fax: 575-356-4839 | |
Gloria Connally, RN, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 701 W 18th St, Portales, NM 88130 Phone: 575-359-6008 | |
Amanda Arredondo, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 501 S Abilene Ave, Portales, NM 88130 Phone: 575-356-7097 | |
Alana Sanchez, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1000 N Avenue M, Portales, NM 88130 Phone: 575-356-7060 Fax: 575-356-4461 | |
Mila Garcia, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1415 S Globe Ave, Portales, NM 88130 Phone: 575-356-7090 Fax: 575-356-2846 | |
Rebecca Kathleen Kizer, FNP-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1812 S Roosevelt Road 8, Portales, NM 88130 Phone: 575-276-8338 Fax: 575-276-8323 |